The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
in the liver there's also a interesting development where um SST are trying to Target a gene called pcsk9 to be able to treat cardiovascular disease and the idea there is so they're going to use a lipid nanoparticle to put into you're going to put in a new pcsk9 Gene that's inactive or you're just going to deliver a vehicle that paralyzes pcsk9
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.